February 26, 2019 Life Science Tools PR/Corporate Product Launch

Latest PacBio Sequencing Advancements Including Preview of Sequel II System to be Featured at Annual AGBT Conference

MENLO PARK, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced its participation in this week’s Advances in Genome Biology & Technology (AGBT) General Meeting taking place February 27-March 2 in Marco Island, FL.Several talks by PacBio customers will... Read more

February 26, 2019 Life Science Tools Microscopy PR/Corporate

Latest PacBio Sequencing Advancements Including Preview of Sequel II System to be Featured at Annual AGBT Conference

MENLO PARK, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced its participation in this week’s Advances in Genome Biology & Technology (AGBT) General Meeting taking place February 27-March 2 in Marco Island, FL.Several talks by PacBio customers will... Read more

February 19, 2019 Licensing, IP, and Legal Life Science Tools

MilliporeSigma Receives First U.S. Patent for Improved CRISPR Genome-Editing Method

News Release February 19, 2019 Your Contact:Media Relationskaren.tiano@emdmillipore.comPhone: +1 978 495 0093 Proxy-CRISPR technology provides solution to improve genome editing and advance new possibilities for research Helps modify difficult-to-access regions of the genome, increasing genome coverage Burlington, Massachusetts, February 19, 2019 — MilliporeSigma, a leader in genome editing, today announced that the United States Patent and... Read more

February 19, 2019 Lab Top-10 Licensing, IP, and Legal Life Science Tools

Merck KGaA, Darmstadt, Germany Receives First U.S. Patent for Improved CRISPR Genome-Editing Method

19 FEB 2019 | DARMSTADT, GERMANY Proxy-CRISPR technology provides solution to improve genome editing and advance new possibilities for research Helps modify difficult-to-access regions of the genome, increasing genome coverage  Merck KGaA, Darmstadt, Germany, a leading science and technology company and leader in genome editing, today announced that the United States Patent and Trademark Office has issued... Read more

February 14, 2019 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools Product Launch

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response

Date: 02/14/2019 HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug... Read more

February 12, 2019 Licensing, IP, and Legal Life Science Tools

Oxford Nanopore prevails against PacBio in decision by US Court of Appeal that upholds ITC ruling

Tue 12th February 2019 – Decision defeats attempts by PacBio to prevent Oxford Nanopore from selling its technology in the US – Oxford Nanopore announces that the US Court of Appeals for the Federal Circuit today upheld the decision of the International Trade Commission (ITC) in favour of Oxford Nanopore. In a complaint previously filed... Read more

February 12, 2019 Life Science Tools Liq. Handling & Robotics Product Launch

Tecan launches NGS DreamPrep™ delivering unprecedented speed and accuracy for automated library preparation

Maennedorf, Switzerland, February 05, 2019 – Tecan today announces the launch of NGS DreamPrep™, a fully-automated approach to next-generation sequencing (NGS) library preparation for research use. This groundbreaking new approach offers quality controlled, sequencing-ready NGS libraries in just a matter of hours, with minimal manual interaction and no sample loss. NGS DreamPrep™ is a full... Read more

February 12, 2019 Life Science Tools Product Launch

New Promega Maxwell® RSC miRNA Plasma and Serum Kit Provides Quick, Automated miRNA Purification for Oncology and Translational Researchers

Madison, WI USA. (February 12, 2019) Promega Corporation’s new Maxwell® RSC miRNA Plasma and Serum Kit offers oncology and translational researchers an easy and automated protocol to purify total circulating RNA, including miRNA, from plasma, serum and enriched exosomes for advance techniques such as NGS or ddPCR. Unlike manual miRNA purification products, the new kit is... Read more

February 7, 2019 Life Science Tools PR/Corporate

IDT backs innovative synthetic biology start-ups with grant awards

CORALVILLE, IA (February 07, 2019) – Demonstrating its commitment to advocating for synthetic biology research, Integrated DNA Technologies’ (IDT) Synthetic Biology Start-up Grant Program has once again benefited innovative start-ups in their missions to impact sustainable manufacturing, human health, and/or humanitarian causes. The program provides much-needed synthetic biology products designed to support the next generation of companies aiming to impact... Read more